Clinical Trials Directory

Trials / Completed

CompletedNCT04944927

HEmiplegia Arrhythmia Retrospective Trial

Role of Alternating Hemiplegia of Childhood Genotype in Cardiac Repolarization. HEART: HEmiplegia Arrhythmia Retrospective Trial

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
12 Months
Healthy volunteers
Not accepted

Summary

Alternating Hemiplegia of Childhood (AHC) is a rare and severe disease that is in need of effective, and hopefully even curative, therapies. Afflicted patients suffer from severe paralyzing crises, often excruciatingly painful muscle spasms, severe often life threatening epileptic seizures, frequently severe developmental and psychiatric/psychological disabilities and other comorbidities, such as cardiac disturbances. Recent data indicate that AHC genotype is in relation to cardiac repolarization troubles and to cardiac arrhythmias. The primary hypothesis to explore is that there is an association between genotype and cardiac phenotype in AHC.

Conditions

Interventions

TypeNameDescription
OTHERRecording of clinical parameters and electrocardiogram parametersRetrospective recording of demographic information (age, sex, age at diagnosis), genetic information, cardiological information, pharmacological treatments, electrocardiogram data. All above data will be deidentified.

Timeline

Start date
2021-04-29
Primary completion
2021-12-29
Completion
2022-06-29
First posted
2021-06-30
Last updated
2023-02-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04944927. Inclusion in this directory is not an endorsement.